Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for In Vitro Functional Assay

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Serena, Elena ^a,b   Cimetta, Elisa ^a,b   Zatti, Susi ^a,b   Zaglia, Tania ^b   Zagallo, Monica ^a,b   Keller, Gordon ^c   Elvassore, Nicola ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; CONNEXIN 43; HYDROGEN PEROXIDE; POLYACRYLAMIDE; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I; TROPONIN T;

ARTICLE; CELL ASSAY; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; ELECTROSTIMULATION; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; EXPOSURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MONITORING;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN PEROXIDE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS;

EID: 84869077819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048483     Document Type: Article

References (47)

1. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotech 25: 1015-1024 doi:10.1038/nbt1327.
2. Habib M, Caspi O, Gepstein L, (2008) Human embryonic stem cells for cardiomyogenesis. J Mol Cell Cardiol 45: 462-474 doi:10.1016/j.yjmcc.2008.08.008.
3. Freund C, Mummery CL, (2009) Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 107: 592-599 doi:10.1002/jcb.22164.
4. Shin DD, Brandimarte F, De Luca L, Sabbah HN, Fonarow GC, et al. (2007) Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am J Cardiol 99: 4A-23A doi:10.1016/j.amjcard.2006.11.025.
5. Wang F, Guan J, (2010) Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv Drug Deliv Rev 62: 784-797 doi:10.1016/j.addr.2010.03.001.
6. Möller C, Slack M, (2010) Impact of new technologies for cellular screening along the drug value chain. Drug Discov Today 15: 384-390 doi:10.1016/j.drudis.2010.02.010.
7. Katare RG, Ando M, Kakinuma Y, Sato T, (2010) Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro. PLoS ONE 5: e9275 doi:10.1371/journal.pone.0009275.
8. Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, et al. (2010) Development of a drug screening platform based on engineered heart tissue. Circ Res 107: 35-44 doi:10.1161/CIRCRESAHA.109.211458.
9. Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, et al. (2008) Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 7: 1003-1010 doi:10.1038/nmat2316.
10. Masuda S, Shimizu T, Yamato M, Okano T, (2008) Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60: 277-285 doi:10.1016/j.addr.2007.08.031.
11. Radisic M, Park H, Shing H, Consi T, Schoen FJ, et al. (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 101: 18129-18134 doi:10.1073/pnas.0407817101.
12. Song H, Yoon C, Kattman SJ, Dengler J, Massé S, et al. (2010) Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci USA 107: 3329-3334 doi:10.1073/pnas.0905729106.
13. Grosberg A, Alford PW, McCain ML, Parker KK (2011) Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip. Lab on a Chip. Available:http://www.ncbi.nlm.nih.gov/pubmed/22072288. Accessed 23 November 2011.
14. Kim SB, Bae H, Cha JM, Moon SJ, Dokmeci MR, et al. (2011) A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip 11: 1801-1807 doi:10.1039/c1lc20098d.
15. Shapira-Schweitzer K, Habib M, Gepstein L, Seliktar D, (2009) A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 46: 213-224 doi:10.1016/j.yjmcc.2008.10.018.
16. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, et al. (2007) Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100: 263-272 doi:10.1161/01.RES.0000257776.05673.ff.
17. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, et al. (2011) Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109: 47-59 doi:10.1161/CIRCRESAHA.110.237206.
18. Schaaf S, Shibamiya A, Mewe M, Eder A, Stöhr A, et al. (2011) Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS ONE 6: e26397 doi:10.1371/journal.pone.0026397.
19. Hong J, Edel JB, deMello AJ, (2009) Micro- and nanofluidic systems for high-throughput biological screening. Drug Discovery Today 14: 134-146 doi:10.1016/j.drudis.2008.10.001.
20. Bers DM, (2002) Cardiac excitation-contraction coupling. Nature 415: 198-205 doi:10.1038/415198a.
21. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528 doi:10.1038/nature06894.
22. Serena E, Zatti S, Reghelin E, Pasut A, Cimetta E, et al. (2010) Soft substrates drive optimal differentiation of human healthy and dystrophic myotubes. Integr Biol (Camb) 2: 193-201 doi:10.1039/b921401a.
23. Cimetta E, Pizzato S, Bollini S, Serena E, De Coppi P, et al. (2009) Production of arrays of cardiac and skeletal muscle myofibers by micropatterning techniques on a soft substrate. Biomed Microdevices 11: 389-400 doi:10.1007/s10544-008-9245-9.
24. Zatti S, Zoso A, Serena E, Luni C, Cimetta E, et al. (2012) Micropatterning Topology on Soft Substrates Affects Myoblast Proliferation and Differentiation. Langmuir 28: 2718-2726 doi:10.1021/la204776e.
25. Saggin L, Gorza L, Ausoni S, Schiaffino S, (1989) Troponin I switching in the developing heart. J Biol Chem 264: 16299-16302.
26. Saggin L, Ausoni S, Gorza L, Sartore S, Schiaffino S, (1988) Troponin T switching in the developing rat heart. J Biol Chem 263: 18488-18492.
27. Tandon N, Cannizzaro C, Chao P-HG, Maidhof R, Marsano A, et al. (2009) Electrical stimulation systems for cardiac tissue engineering. Nat Protoc 4: 155-173 doi:10.1038/nprot.2008.183.
28. Serena E, Flaibani M, Carnio S, Boldrin L, Vitiello L, et al. (2008) Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold. Neurol Res 30: 207-214 doi:10.1179/174313208X281109.
29. Cannizzaro C, Tandon N, Figallo E, Park H, Gerecht S, et al. (2007) Practical aspects of cardiac tissue engineering with electrical stimulation. Methods Mol Med 140: 291-307.
30. Available: http://rsbweb.nih.gov/.
31. Cimetta E, Franzoso M, Trevisan M, Serena E, Zambon A, et al. (2012) Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study. Biomicrofluidics 6doi:10.1063/1.4723853.
32. Engler AJ, Sen S, Sweeney HL, Discher DE, (2006) Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689 doi:10.1016/j.cell.2006.06.044.
33. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang H-Y, et al. (2008) Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci 121: 3794-3802 doi:10.1242/jcs.029678.
34. Giaume C (2001) Connexin methods and protocols. Humana Press. 504 p.
35. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB, (1997) Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571-2583 doi:10.1006/jmcc.1997.0497.
36. Robey TE, Saiget MK, Reinecke H, Murry CE, (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581 doi:10.1016/j.yjmcc.2008.03.009.
37. Cook SA, Sugden PH, Clerk A, (1999) Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949.
38. Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R, et al. (2010) Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4: 107-116 doi:10.1016/j.scr.2009.11.004.
39. Jonsson MKB, Duker G, Tropp C, Andersson B, Sartipy P, et al. (2010) Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4: 189-200 doi:10.1016/j.scr.2010.02.001.
40. Pera MF, Tam PPL, (2010) Extrinsic regulation of pluripotent stem cells. Nature 465: 713-720 doi:10.1038/nature09228.
41. Radisic M, Fast VG, Sharifov OF, Iyer RK, Park H, et al. (2009) Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng Part A 15: 851-860 doi:10.1089/ten.tea.2008.0223.
42. Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, et al. (2004) Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 286: H507-516 doi:10.1152/ajpheart.00171.2003.
43. Dolnikov K, Shilkrut M, Zeevi-Levin N, Gerecht-Nir S, Amit M, et al. (2006) Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24: 236-245 doi:10.1634/stemcells.2005-0036.
44. Au HTH, Cheng I, Chowdhury MF, Radisic M, (2007) Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials 28: 4277-4293 doi:10.1016/j.biomaterials.2007.06.001.
45. Heidi Au HT, Cui B, Chu ZE, Veres T, Radisic M, (2009) Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip 9: 564-575 doi:10.1039/b810034a.
46. Lamb GD, Westerblad H, (2011) Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle. J Physiol (Lond) 589: 2119-2127 doi:10.1113/jphysiol.2010.199059.
47. Greensmith DJ, Eisner DA, Nirmalan M, (2010) The effects of hydrogen peroxide on intracellular calcium handling and contractility in the rat ventricular myocyte. Cell Calcium 48: 341-351 doi:10.1016/j.ceca.2010.10.007.